After the BBC hyped this up last night I had a peek at the
lancet paper- surprise, surprise, the results are not quite
so dramatic as I had been led to believe.
They made it sound that all patients should run out and
demand to be changed over.
NNT 5.75 yrs
Dis free survival 41
Time to recurrence 32
Distant mets 61
Contralateral Ca 129
And as yet no improvement in overall survival time., but
as the authors say it is still too early.
And the prize of Arimidex is dropping by 18% in the new year.
£83 --> £69 per month.
Would it be too cynical to suggest a link?
David Jobson
|